Bernstein Reinstates Outperform on Guardant Health, Announces $175 Price Target
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsInitiationPrice Target
Bernstein analyst Eve Burstein reinstates Guardant Health (NASDAQ:GH) with a Outperform and announces $175 price target.
Bernstein analyst Eve Burstein reinstates Guardant Health (NASDAQ:GH) with a Outperform and announces $175 price target.